Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Effects of MetAP2 Inhibition on Bioenergetics and Aging-associated Characteristics in Adipose Tissue (BIO-AGE) in Healthy Participants

Authors not listed

AdventHealth Translational Research Institute · 2020

Abstract

This study is being done to collect Adipose tissue from young and older individuals and gather data on the effect of methionine aminopeptidase protein (MetAP2) inhibition on that Adipose tissue in the laboratory.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-16 MST

Cite this

APA
Anonymous. (2020). Effects of MetAP2 Inhibition on Bioenergetics and Aging-associated Characteristics in Adipose Tissue (BIO-AGE) in Healthy Participants. <em>AdventHealth Translational Research Institute</em>. https://clinicaltrials.gov/study/NCT05989035
Vancouver
Anonymous. Effects of MetAP2 Inhibition on Bioenergetics and Aging-associated Characteristics in Adipose Tissue (BIO-AGE) in Healthy Participants. AdventHealth Translational Research Institute. 2020.
BibTeX
@misc{anon2020Effect, title = {Effects of MetAP2 Inhibition on Bioenergetics and Aging-associated Characteristics in Adipose Tissue (BIO-AGE) in Healthy Participants}, author = {Anonymous}, journal = {AdventHealth Translational Research Institute}, year = {2020}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings

CHEST Journal 2020
Citation only

Senotherapy

▲ 70